AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Intimation Of Board Meeting
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve This is to inform you that the next meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 6, 2O2O. Aarti Drugs Ltd - 524348 - Shareholding for the Period Ended December 31, 2019
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
Govt may impose anti-dumping duty on a medicine from China
The commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR) has initiated a probe into an alleged dumping of Ciprofloxacin Hydrochloride from China following a complaint filed by Aarti Drugs Ltd. AARTI DRUGS LTD. - 524348 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Rushikesh DeoleDesignation :- Company Secretary and Compliance Officer Aarti Drugs Ltd - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclose herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 received from Link Intime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. Aarti Drugs incorporates wholly-owned subsidiary at UAE International Free Zone Authority
Aarti Drugs has incorporated a wholly-owned subsidiary Pinnacle Life Science LLC, at the International Free Zone Authority, Fujairah, United Arab Emir AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that Company has incorporated a Wholly Owned Subsidiary (WOS) Company namely 'Pinnacle Life Science LLC' registered with International Free Zone Authority, Fujairah at United Arab Emirates (U.A.E.) on January 5, 2020. Aarti Drugs Ltd - 524348 - Closure Of Trading Window
This is to inform that the Trading Window of the Company will remain closed from Wednesday, January 1, 2020 until the expiry of 48 hours after the declaration of financial results of the Company for the quarter and nine months ended December 31, 2019. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This is to inform you that Mr. Adhish P. Patil, Chief Financial Officer of the Company had a meeting with Senior Research Analyst of Phillip Capital (India) Private Limited on December 23, 2019. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Regulation 30(6) of SEBI (LODR) Regulations, 2015